82 related articles for article (PubMed ID: 15927674)
1. Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells.
Saiko P; Horvath Z; Illmer C; Madlener S; Bauer W; Hoechtl T; Erlach N; Grusch M; Krupitza G; Mader RM; Jaeger W; Schott H; Agarwal RP; Fritzer-Szekeres M; Szekeres T
Leuk Res; 2005 Jul; 29(7):785-91. PubMed ID: 15927674
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
Rauko P; Novotny L; Mego M; Saiko P; Schott H; Szekeres T
Neoplasma; 2007; 54(1):68-74. PubMed ID: 17203895
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitumor activity of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
Saiko P; Horvath Z; Bauer W; Hoechtl T; Grusch M; Krupitza G; Rauko P; Mader RM; Jaeger W; Schott H; Novotny L; Fritzer-Szekeres M; Szekeres T
Int J Oncol; 2004 Aug; 25(2):357-64. PubMed ID: 15254732
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
Saiko P; Bauer W; Horvath Z; Hoechtl T; Grusch M; Illmer C; Madlener S; Krupitza G; Mader RM; Schott H; Fritzer-Szekeres M; Szekeres T
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1507-11. PubMed ID: 15571287
[TBL] [Abstract][Full Text] [Related]
5. Avemar, a nontoxic fermented wheat germ extract, attenuates the growth of sensitive and 5-FdUrd/Ara-C cross-resistant H9 human lymphoma cells through induction of apoptosis.
Saiko P; Ozsvar-Kozma M; Graser G; Lackner A; Grusch M; Madlener S; Krupitza G; Jaeger W; Hidvegi M; Agarwal RP; Fritzer-Szekeres M; Szekeres T
Oncol Rep; 2009 Mar; 21(3):787-91. PubMed ID: 19212640
[TBL] [Abstract][Full Text] [Related]
6. 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
Strasser S; Maier S; Leisser C; Saiko P; Madlener S; Bader Y; Bernhaus A; Gueorguieva M; Richter S; Mader RM; Wesierska-Gadek J; Schott H; Szekeres T; Fritzer-Szekeres M; Krupitza G
Differentiation; 2006 Dec; 74(9-10):488-98. PubMed ID: 17177846
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.
Maier S; Strasser S; Saiko P; Leisser C; Sasgary S; Grusch M; Madlener S; Bader Y; Hartmann J; Schott H; Mader RM; Szekeres T; Fritzer-Szekeres M; Krupitza G
Apoptosis; 2006 Mar; 11(3):427-40. PubMed ID: 16538382
[TBL] [Abstract][Full Text] [Related]
8. Heterodinucleoside phosphates of 5-fluorodeoxyuridine and arabinofuranosylcytosine--new drugs in cancer chemotherapy?
Saiko P; Horvath Z; Jaeger W; Schott H; Fritzer-Szekeres M; Szekeres T
In Vivo; 2005; 19(1):205-14. PubMed ID: 15796176
[TBL] [Abstract][Full Text] [Related]
9. Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.
Rauko P; Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Schott H; Fritzer-Szekeres M; Novotny L; Szekeres T
Anticancer Res; 2003; 23(5A):3841-6. PubMed ID: 14666686
[TBL] [Abstract][Full Text] [Related]
10. Induction of cell cycle-dependent cytotoxicity and apoptosis by new heterodinucleoside phosphate dimers of 5-fluorodeoxyuridine in PC-3 human prostate cancer cells.
Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Derighetti M; Schwendener RA
Biochem Pharmacol; 2000 Dec; 60(12):1887-96. PubMed ID: 11108805
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-selective activation of 5-fluorodeoxyuridine prodrug possessing indolequinone structure: radiolytic reduction and cytotoxicity characteristics.
Tanabe K; Makimura Y; Tachi Y; Imagawa-Sato A; Nishimoto S
Bioorg Med Chem Lett; 2005 May; 15(9):2321-4. PubMed ID: 15837317
[TBL] [Abstract][Full Text] [Related]
13. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells.
Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Rothen-Rutishauser B; Guenthert M; Schwendener RA
J Cancer Res Clin Oncol; 2000 May; 126(5):247-56. PubMed ID: 10815759
[TBL] [Abstract][Full Text] [Related]
14. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
Kanno S; Hiura T; Ohtake T; Koiwai K; Suzuki H; Ujibe M; Ishikawa M
Clin Chim Acta; 2007 Feb; 377(1-2):144-9. PubMed ID: 17097625
[TBL] [Abstract][Full Text] [Related]
15. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and one-electron reduction characteristics of radiation-activated prodrugs possessing two 5-fluorodeoxyuridine units.
Tanabe K; Sugiura M; Ito T; Nishimoto S
Bioorg Med Chem; 2012 Sep; 20(17):5164-8. PubMed ID: 22847019
[TBL] [Abstract][Full Text] [Related]
17. Reductive activation of 5-fluorodeoxyuridine prodrug possessing azide methyl group by hypoxic X-irradiation.
Tanabe K; Ishizaki J; Ando Y; Ito T; Nishimoto S
Bioorg Med Chem Lett; 2012 Feb; 22(4):1682-5. PubMed ID: 22248856
[TBL] [Abstract][Full Text] [Related]
18. The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145.
Cattaneo-Pangrazzi RM; Schott H; Schwendener RA
Prostate; 2000 Sep; 45(1):8-18. PubMed ID: 10960838
[TBL] [Abstract][Full Text] [Related]
19. Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus.
Yusa K; Oh-hara T; Tsuruo T
Biochem Biophys Res Commun; 1995 Jan; 206(2):486-91. PubMed ID: 7826366
[TBL] [Abstract][Full Text] [Related]
20. Lack of dependence of 5-fluorodeoxyuridine-mediated radiosensitization on cytotoxicity.
Lawrence TS; Davis MA; Chang EY; Canman CE; Maybaum J; Radany EH
Radiat Res; 1995 Sep; 143(3):281-5. PubMed ID: 7652165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
